200 related articles for article (PubMed ID: 26612336)
21. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
22. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
[TBL] [Abstract][Full Text] [Related]
23. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference.
Nolan CM; Longworth L; Lord J; Canavan JL; Jones SE; Kon SS; Man WD
Thorax; 2016 Jun; 71(6):493-500. PubMed ID: 27030578
[TBL] [Abstract][Full Text] [Related]
24. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.
Greene ME; Rader KA; Garellick G; Malchau H; Freiberg AA; Rolfson O
Clin Orthop Relat Res; 2015 Nov; 473(11):3383-90. PubMed ID: 25488404
[TBL] [Abstract][Full Text] [Related]
25. Do English and Chinese EQ-5D versions demonstrate measurement equivalence? An exploratory study.
Luo N; Chew LH; Fong KY; Koh DR; Ng SC; Yoon KH; Vasoo S; Li SC; Thumboo J
Health Qual Life Outcomes; 2003 Apr; 1():7. PubMed ID: 12756060
[TBL] [Abstract][Full Text] [Related]
26. Examining the psychometric properties of a split version of the EQ-5D-5L anxiety/depression dimension in patients with anxiety and/or depression.
Belay YB; Mihalopoulos C; Lee YY; Mulhern B; Engel L
Qual Life Res; 2023 Jul; 32(7):2025-2036. PubMed ID: 36809437
[TBL] [Abstract][Full Text] [Related]
27. Validation of the Mobile App Version of the EQ-5D-5L Quality of Life Questionnaire Against the Gold Standard Paper-Based Version: Randomized Crossover Study.
Kamstra RJM; Boorsma A; Krone T; van Stokkum RM; Eggink HM; Peters T; Pasman WJ
JMIR Form Res; 2022 Aug; 6(8):e37303. PubMed ID: 35969437
[TBL] [Abstract][Full Text] [Related]
28. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
Martin A; Meads D; Griffiths AW; Surr CA
Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
[TBL] [Abstract][Full Text] [Related]
29. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
30. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases.
Scalone L; Ciampichini R; Fagiuoli S; Gardini I; Fusco F; Gaeta L; Del Prete A; Cesana G; Mantovani LG
Qual Life Res; 2013 Sep; 22(7):1707-16. PubMed ID: 23192232
[TBL] [Abstract][Full Text] [Related]
31. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
32. A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice.
Lam CLK; Tse ETY; Wong CKH; Lam JSM; Chen SS; Bedford LE; Cheung JPY; Or CK; Kind P
Health Qual Life Outcomes; 2021 Dec; 19(1):266. PubMed ID: 34922564
[TBL] [Abstract][Full Text] [Related]
33. Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey.
Hołownia-Voloskova M; Tarbastaev A; Golicki D
Qual Life Res; 2021 Mar; 30(3):831-840. PubMed ID: 33237551
[TBL] [Abstract][Full Text] [Related]
34. DEEP Study: does EQ-5D-5L measure the impacts of persistent oro-facial pain?
Durham J; Steele JG; Breckons M; Story W; Vale L
J Oral Rehabil; 2015 Sep; 42(9):643-50. PubMed ID: 25818477
[TBL] [Abstract][Full Text] [Related]
35. Psychometric properties of the EQ-5D-5L in the general population of South Korea.
Kim TH; Jo MW; Lee SI; Kim SH; Chung SM
Qual Life Res; 2013 Oct; 22(8):2245-53. PubMed ID: 23224560
[TBL] [Abstract][Full Text] [Related]
36. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.
Shafie AA; Vasan Thakumar A; Lim CJ; Luo N
Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426
[TBL] [Abstract][Full Text] [Related]
37. Validity of EQ-5D-5L in stroke.
Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
[TBL] [Abstract][Full Text] [Related]
38. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.
Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J
Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
[TBL] [Abstract][Full Text] [Related]
40. EQ-5D-5L Slovenian population norms.
Prevolnik Rupel V; Ogorevc M
Health Qual Life Outcomes; 2020 Oct; 18(1):333. PubMed ID: 33028345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
